Recent research highlights metabolic acidosis as a potentially significant contributor to age-related frailty, characterized by chronic inflammation, muscle mass loss, and diminished immune resilience. The study underscores the need for deeper exploration into how acid-base dysregulation impacts aging, particularly given that metabolic acidosis reflects a failure to maintain optimal pH levels in tissues. This failure can lead to a cascade of metabolic derangements that are not only associated with frailty but also with broader implications for aging biology.

The authors emphasize that even mild deviations in serum bicarbonate levels, traditionally considered within normal clinical ranges, can have profound effects on physical performance in older adults. Specifically, serum bicarbonate levels below 25 mEq/L correlate with slower gait speeds, reduced muscle strength, and increased risk of functional limitations. Notably, low bicarbonate levels remain a significant mortality risk factor, even in individuals with preserved renal function. The mechanisms proposed include catabolic signaling, insulin resistance, and mitochondrial dysfunction, all of which contribute to sarcopenia and the frailty phenotype.

This research shifts the paradigm in aging studies by suggesting that metabolic acidosis should be a focal point in understanding frailty. It opens avenues for therapeutic interventions aimed at correcting acid-base imbalances as a means to enhance healthspan and mitigate frailty in the elderly. As the field progresses, longitudinal studies tracking pH levels alongside frailty onset will be crucial in determining whether metabolic acidosis is a driving factor, a marker, or a consequence of muscle degradation, thereby refining our understanding of aging processes and potential therapeutic targets.

Source: fightaging.org